Coppo R, Amore A, Gianoglio B, Cacace G, Picciotto G, Roccatello D, Peruzzi L, Piccoli G, De Filippi P G
Nephrology and Dialysis Department, Regina Margherita Children's Hospital, Torino, Italy.
Am J Kidney Dis. 1993 Jun;21(6):593-602. doi: 10.1016/s0272-6386(12)80031-x.
Immunologic and hemodynamic factors are likely to work in synergism in the progression of immunoglobulin A nephropathy (IgAN) toward sclerosis. The local activation of the renin-angiotensin system may be one the most relevant mechanisms. We investigated the hemodynamic effects of the acute administration of angiotensin-converting enzyme inhibitor (ACEI) (captopril 50 mg). The glomerular filtration rate (GFR) and the effective renal plasma flow (ERPF) were measured by 51Cr-EDTA and 125I hippurate clearances. The correspondent filtration fractions (FFs) in basal conditions and after administration of ACEI were calculated, then the changes in FF (delta FF and % delta FF) were determined. We studied 27 IgAN patients. Eighteen patients had normal renal function (GFR, 112 +/- 19 mL/min/1.73 m2) and nine had moderate renal impairment (GFR, 54 +/- 13 mL/min/1.73 m2). Sixteen patients had proteinuria > or = 0.5 g/d. In addition, 12 glomerulonephritis control cases and eight healthy subjects were investigated. After the administration of ACEI in healthy subjects we observed slight modifications in the GFR, a significant increase in the ERPF (P < 0.005), and a significant decrease in FF (P < 0.04). Similarly, in IgAN patients with normal renal function the GFR increased slightly, the ERPF increased significantly (P < 0.01), and there was a decrease in FF (P < 0.01). The delta FF and % delta FF values were not significantly different from those found in the controls. In patients with initial renal failure GFR remained unchanged, ERPF increased significantly (P < 0.005), and FF significantly decreased (P < 0.004). However, the changes in delta FF and % delta FF were significantly greater than those found in healthy controls (P < 0.01) and in IgAN patients with normal renal function (P < 0.001). IgAN patients with proteinuria levels > or = 0.5 g/d showed greater changes in delta FF and % delta FF after the administration of ACEI than patients with proteinuria levels lower than 0.5 g/d (P < 0.003 and P < 0.04, respectively) or proteinuric control cases (P < 0.05 and P < 0.01, respectively). This different response in proteinuric and nonproteinuric patients was evident even when the analysis was limited to the subgroup of IgAN patients with normal renal function. The decrease in FF consequent to an increase in the ERPF after the administration of ACEI suggests a local hyperactivity of the renin-angiotensin system in some cases of IgAN.(ABSTRACT TRUNCATED AT 400 WORDS)
免疫和血流动力学因素可能在免疫球蛋白A肾病(IgAN)向硬化进展过程中协同作用。肾素 - 血管紧张素系统的局部激活可能是最相关的机制之一。我们研究了急性给予血管紧张素转换酶抑制剂(ACEI)(卡托普利50毫克)的血流动力学效应。通过51Cr - EDTA和125I马尿酸盐清除率测量肾小球滤过率(GFR)和有效肾血浆流量(ERPF)。计算基础状态下和给予ACEI后的相应滤过分数(FF),然后确定FF的变化(ΔFF和%ΔFF)。我们研究了27例IgAN患者。18例患者肾功能正常(GFR,112±19 mL/min/1.73 m2),9例有中度肾功能损害(GFR,54±13 mL/min/1.73 m2)。16例患者蛋白尿≥0.5 g/d。此外,研究了12例肾小球肾炎对照病例和8例健康受试者。在健康受试者给予ACEI后我们观察到GFR有轻微改变,ERPF显著增加(P<0.005),FF显著降低(P<0.04)。同样,在肾功能正常的IgAN患者中,GFR略有增加,ERPF显著增加(P<0.01),FF降低(P<0.01)。ΔFF和%ΔFF值与对照组无显著差异。在初始肾衰竭患者中,GFR保持不变,ERPF显著增加(P<0.005),FF显著降低(P<0.004)。然而,ΔFF和%ΔFF的变化显著大于健康对照组(P<0.01)和肾功能正常的IgAN患者(P<0.001)。蛋白尿水平≥0.5 g/d的IgAN患者给予ACEI后,ΔFF和%ΔFF的变化大于蛋白尿水平低于0.5 g/d的患者(分别为P<0.003和P<0.04)或蛋白尿对照病例(分别为P<0.05和P<0.01)。即使分析仅限于肾功能正常的IgAN患者亚组,蛋白尿和非蛋白尿患者的这种不同反应也很明显。给予ACEI后ERPF增加导致FF降低表明在某些IgAN病例中肾素 - 血管紧张素系统局部活性过高。(摘要截短至400字)